Metropolis Healthcare Limited
NSE: METROPOLISINE112L01020·HealthcareMicrocap 250·www.metropolisindia.com ↗·Mcap ₹12,149 Cr·Listed 2019
₹582.60▼ ₹0.35  (−0.06%)
52W: ₹412 – ₹609 · Vol: 1.3L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY19
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19
Revenue from operations4504254064293863453233503133312913092772832853002803062933033272922752881432072232232030
Other income5.18.290.97.572.63.12.52.52.31.23.11.26.64.335.72.65.63.82.13.73.13.23.12.221.50
Total expenses3783633493593323162832922652832572622412422442502402552402302432122012101431691721721580
EBITDA11110894.810889.862.37289.978.88064.874.862.970.370.57968.574.875.390.210296.486.690.912.151.463.662.6550
EBITDA margin24.7%25.4%23.4%25.2%23.2%18.0%22.3%25.7%25.2%24.2%22.3%24.2%22.7%24.9%24.7%26.3%24.5%24.5%25.7%29.8%31.3%33.0%31.5%31.5%8.5%24.8%28.5%28.0%27.1%–
Finance costs6.27.95.75.75.24.64.54.84.75.65.35.766.26.177.56.153.15.62.71.61.51.92.32.41.91.80
Depreciation32.438.631.932.430.828.627.726.825.526.42522.220.823.42321.621.21816.91513.314.111119.911.110.69.38.30
Profit before tax77.769.857.27161.23642.361.451.150.536.948.139.241.94854.842.856.556.177.710381.777.881.43.523.452.853.439.70
Tax20.818.815.118.1166.810.914.713149.612.510.28.412.114.39.316.314.919.328.220.319.120.90.67.910.810.112.40
Net profit56.95142.152.945.229.231.546.738.136.527.335.72933.535.940.533.640.141.258.474.961.358.660.52.915.54243.126.90
Net margin12.6%12.0%10.4%12.3%11.7%8.5%9.8%13.4%12.2%11.0%9.4%11.6%10.5%11.9%12.6%13.5%12.0%13.1%14.1%19.3%22.9%21.0%21.3%21.0%2.0%7.5%18.9%19.3%13.2%–
EPS (₹)2.732.467.9910.178.705.696.119.087.417.115.306.925.626.516.997.886.537.818.0211.3914.6512.0511.5011.880.573.098.388.575.340.00
Net profit YoY+25.7%+74.3%+33.7%+13.3%+18.7%−20.0%+15.3%+31.0%+31.5%+9.1%−23.9%−11.9%−13.7%−16.6%−13.0%−30.7%−55.2%−34.5%−29.7%−3.5%+2502.6%+295.8%+39.6%+40.3%−89.3%–––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19
Revenue from operations1,6461,3311,2081,1481,228998856761
Other income25.615.19.115.217.6128.68.2
Total expenses1,4031,1551,042976969766671581
EBITDA401303283288343286233200
EBITDA margin24.4%22.8%23.4%25.1%27.9%28.7%27.2%26.3%
Finance costs24.518.622.526.819.77.88.30.5
Depreciation13410994.589.263.245.939.320.1
Profit before tax259191175188293244169187
Tax6845.346.244.178.76141.262.9
Net profit191146128143215183128124
Net margin11.6%10.9%10.6%12.5%17.5%18.4%14.9%16.2%
EPS (₹)9.1928.2924.9527.9141.8735.9725.3624.06
Net profit YoY+31.4%+13.3%−10.4%−33.2%+17.1%+43.7%+3.2%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow351263264247253
Investing cash flow−223−201−89.446.8−735
Financing cash flow−115−86.6−181−292163
Capital expenditure43.543.463.852.630.7
Free cash flow (CFO − capex)307219200194223

Net profit trend

annual, ₹ crore
FY21
₹183
FY22
₹215+17%
FY23
₹143−33%
FY24
₹128−10%
FY25
₹146+13%
FY26
₹191+31%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated4 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone4 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited13 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited13 May 2026PDF on NSE XBRL
Q3 FY26Consolidated4 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone4 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated4 Nov 2025 PDF XBRL
Q2 FY26Standalone4 Nov 2025 PDF XBRL
Q1 FY26Consolidated7 Aug 2025PDF on NSE XBRL
Q1 FY26Standalone7 Aug 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 54.4×59.6×
P/B5Y avg 7.42×7.98×
ROEFY26, on average equity13.4%
Net margin11.6%
Debt / equity0.01×
Revenue CAGR (3Y)12.8%
Profit CAGR (3Y)10.1%
EPS (TTM)₹9.78
Market cap₹12,079 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
7.98×
vs 8-point avg 7.42× (+8%)
5.95× low7.42× avg9.60× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹2,138 Cr+14%
Net worth₹1,513 Cr+14%
Total borrowings₹19 Cr+32%
Cash & bank balances₹55 Cr+39%
Investments₹142 Cr+101%
Inventories₹45 Cr−5%
Trade receivables₹170 Cr+15%
Trade payables₹129 Cr+3%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23
Promoter48.8648.8748.8748.8848.8948.8948.9049.4049.4349.6249.6749.74
FII11.0310.4310.7711.6912.5212.8315.2916.7318.5618.2518.9021.66
DII35.1235.7935.4634.7333.1032.4030.3030.0028.0227.4324.8620.73
of which MF32.6733.2832.9332.2230.6929.81––––––
Retail4.063.994.023.873.694.163.843.343.544.075.246.63
Other public0.930.920.880.831.801.721.670.530.450.631.331.24
50,636 shareholders · NSE shareholding pattern filings.